Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-16 Sale |
2023-11-17 8:01 pm |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
7,313 | $10.92 | $79,858 | 112,714 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-17 8:00 pm |
Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer |
5,255 | $10.92 | $57,385 | 72,245 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 9:02 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,658 | $20.01 | $113,214 | 435,802 (Direct) |
View |
| 2023-08-22 Sale |
2023-08-24 8:30 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
18,600 | $20.01 | $372,186 | 390,877 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-15 8:30 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
1,400 | $20 | $28,000 | 368,727 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-11 9:00 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
20,000 | $21.58 | $431,541 | 410,877 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:01 pm |
Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer |
12,860 | $24.06 | $309,395 | 135,293 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:00 pm |
Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer |
5,698 | $24.04 | $137,008 | 148,873 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:36 pm |
Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer |
15,575 | $18.05 | $281,129 | 154,571 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:35 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
7,861 | $18.05 | $141,891 | 1,833,336 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:34 pm |
Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer |
12,207 | $18.05 | $220,336 | 148,153 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:33 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
10,775 | $18.05 | $194,489 | 794,960 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:32 pm |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
11,351 | $18.05 | $204,886 | 128,748 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:31 pm |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
771 | $18.05 | $13,917 | 120,027 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:31 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,966 | $18.05 | $107,686 | 263,436 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 8:30 pm |
Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer |
17,902 | $18.05 | $323,131 | 1,525,278 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 8:01 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $25.03 | $375,450 | 265,605 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-01 Option Award |
2024-04-03 8:00 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Levitsky Hyam Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:00 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer |
71,100 | $0 | 93,861 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-20 8:04 pm |
N/A 2033-09-18 |
Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer |
208,330 | $0 | 208,330 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 9:02 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,658 | $3.3 | 435,802 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 9:02 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,658 | $0 | 435,802 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 8:30 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
13,600 | $3.3 | 390,877 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 8:30 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $15.5 | 390,877 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 8:30 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
18,600 | $0 | 390,877 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-15 8:30 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
1,400 | $3.3 | 368,727 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-15 8:30 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
1,400 | $0 | 368,727 (Direct) |
View |
Ownership |
2023-07-26 8:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer |
0 | $0 | 193,750 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 9:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $3.3 | 410,877 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 9:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $15.5 | 410,877 (Direct) |
View |
| 2023-07-10 Exercise |
2023-07-11 9:00 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
20,000 | $0 | 410,877 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 08:13 am |
N/A 2033-06-01 |
Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director |
50,400 | $0 | 50,400 (Direct) |
View |
Ownership |
2023-05-18 8:37 pm |
N/A N/A |
Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer |
0 | $0 | 125,000 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:04 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Slootweg Hugo Alexander Director |
25,200 | $0 | 25,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:04 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Pucci Paolo Director |
25,200 | $0 | 25,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:03 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
25,200 | $0 | 25,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:03 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
25,200 | $0 | 25,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:03 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Levitsky Hyam Director |
25,200 | $0 | 25,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:03 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Weinand Dieter Director |
37,800 | $0 | 37,800 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:02 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Oliger Christy J. Director |
25,200 | $0 | 25,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:02 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
100,000 | $0 | 329,402 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:02 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
125,000 | $0 | 195,798 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:01 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
112,500 | $0 | 207,599 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:01 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
100,000 | $0 | 865,735 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:01 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer |
100,000 | $0 | 220,360 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:01 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer |
100,000 | $0 | 230,146 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:00 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
112,500 | $0 | 1,908,697 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 8:00 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer |
355,250 | $0 | 1,756,330 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 8:01 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $0 | 265,605 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 8:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
15,000 | $1.01 | 265,605 (Direct) |
View |